A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.
Spasticity in multiple sclerosis was the most common condition cited by the doctors for treatment with medical cannabis, ...
A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...
StarsInsider on MSN5h
Everything you need to know about multiple sclerosisThe world is full of nasty and deadly diseases, but some of the worst are the ones that turn your own body against you.
VANCOUVER, BC / / February 19, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), ...
Multiple Sclerosis Association of America is proud to support Multiple Sclerosis Awareness Month during the month of March ...
A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...
A sponge-like implant in mice has helped guide a treatment that slowed or stopped a degenerative condition similar to ...
A study suggests daily summer sun exposure in infancy and during pregnancy may be linked to lower relapse risk in children diagnosed with MS.
Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...
This segment is sponsored by Genetech.March is Multiple Sclerosis Awareness Month, but how much do you really know about this chronic disease?Today on Living O ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results